Eric First, M.D.
Eric R First: Therapy for melanin related afflictions. Allergan, Allergan, January 17, 2008: US20080014159-A1

Methods for treating melanin related afflictions by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a melanin related affliction.

Rajiv Banavali
Rajiv Manohar Banavali, Abraham Benderly: Method for transesterification of triglycerides. Rohm And Haas Company, January 17, 2008: US20080015375-A1

A method for transesterification of triglycerides, especially those containing free fatty acids, with methanol. The method uses a catalyst derived from an acidic ion exchange resin. The catalyst is contacted with a reaction mixture containing a triglyceride and methanol under conditions suitable for ...

Steven Jobs
Steve Jobs, Anthony M Fadell, Jonathan P Ive: Highly portable media device. Apple, Beyer Weaver Apple, January 17, 2008: US20080013274-A1

An improved portable media device and methods for operating a media device are disclosed. According to one aspect, the portable media device can also function as a solid-state drive for data storage. The form factor of the portable media device can be hand-held or smaller, such that it is highly por ...

Matthias Bauer
Matthias Bauer: Dual channel heterostructure. Knobbe Martens Olsen & Bear, January 17, 2008: US20080014721-A1

Dual channel heterostructures comprising strained Si and strained Ge-containing layers are disclosed, along with methods for producing such structures. In preferred embodiments, a strain-relaxed buffer layer is deposited on a carrier substrate, a strained Si layer is deposited over the strain-relaxe ...

Dokai Yuya, Kato Noboru: Antenna and radio ic device. Murata Manufacturing, Dokai Yuya, Kato Noboru, MORISHITA Takekazu, January 17, 2008: WO/2008/007606 (85 worldwide citation)

It is possible to provide an antenna capable of effectively transmitting and receiving electromagnetic waves and a radio IC device which can be easily assembled and can obtain a desired radiation characteristic and directivity. The antenna includes a power feed terminal and an oscillation circuit. T ...

Nakazato Kazuo: Material detection device. National University Corporation Nagoya University, Nakazato Kazuo, FUJITANI Osamu, January 17, 2008: WO/2008/007716 (72 worldwide citation)

[PROBLEMS] To downsize a material detection device and realize high detection accuracy. [MEANS FOR SOLVING PROBLEMS] A charge detecting field effect transistor and its control circuit are built in each of cells so as to control the drain-source voltage and a drain current of the charge detecting fie ...


Phadke Avinash, Wang Xiangzhu, Zhang Suoming, Agarwal Atul: 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication. Achillion Pharmaceuticals, Phadke Avinash, Wang Xiangzhu, Zhang Suoming, Agarwal Atul, LECUYER Karen A, January 17, 2008: WO/2008/008502 (44 worldwide citation)

The invention rovides 4-amino-4-oxobutanoyl peptide compounds of Formula I (I) and the pharmaceutically salts and hydrates thereof. The variables R1-R9, R16, R18 R19, n, M,, n, M,, and Z are defined herein. Certain compounds of Formula I are useful as antiviral agents. Certain 4-amino-4-oxobutanoyl ...

Abram Albert Zorko, Goldstein Iulian: Fatty acid pharmaceutical foam. Stiefel Research Australia, Stiefel Laboratories, Abram Albert Zorko, Goldstein Iulian, NATH Gary M, January 17, 2008: WO/2008/008397 (44 worldwide citation)

The present invention provides a foamable composition comprising water and an organic solvent, wherein the organic solvent comprises a fatty acid. The composition may further comprise a pharmaceutically active agent. The composition of the invention is also useful for the treatment of a dermatologic ...

Scola Paul Michael, Sun Li Qiang: Hepatitis c virus inhibitors. Bristol Myers Squibb Company, Scola Paul Michael, Sun Li Qiang, MINGO Pamela A, January 17, 2008: WO/2008/008776 (40 worldwide citation)

Hepatitis C virus inhibitors having the general Formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Click the thumbnails below to visualize the patent trend.